Accuray Incorporated announced that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company's Radixact® System, equipped with its proprietary ClearRT®, Synchrony® and VOLO? Ultra Optimizer solutions, to help transform their approach to cancer care. The full-featured system is designed to help provide the certainty necessary to effectively and efficiently treat the wide range of cancer cases seen daily in a busy oncology practice.

The Radixact System will replace the older generation Accuray TomoTherapy® System. Heidelberg University Hospital was an early adopter of image-guided intensity modulated radiation therapy (IG-IMRT), a targeted form of external beam radiation therapy that uses images acquired before each treatment to help ensure accurate patient and tumor positioning before delivery of the radiation. Two Tomo Therapy Systems enabled the hospital's team to treat up to 100 patients per day while leveraging the benefits of full image guidance made possible by IG-IMRT.

The Radixact System integrated with ClearRT helical fan-beam kVCT imaging, Synchrony motion tracking and synchronization technology, and VOLO Ultra Optimizer offers an enhanced workflow along with improved image clarity, enhanced precision, and the versatility necessary to treat more patients, better and faster. The hospital joins renowned facilities across the United States, Europe and Asia in adopting the integrated Accuray solutions. Over their more than 100-year history, the hospital's center for radiation oncology has become one of the largest and most modern institutions around the globe, focusing on patient treatment as well as preclinical cancer research.